{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:25:22Z","timestamp":1784784322935,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00520-023-07835-y","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T05:02:16Z","timestamp":1686027736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Health-related quality of life and use of medication with anticholinergic activity in patients with multiple myeloma"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7975-649X","authenticated-orcid":false,"given":"Mariana Sampaio Rodrigues","family":"de Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7083-3188","authenticated-orcid":false,"given":"Cristiane Aparecida Menezes","family":"de P\u00e1dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4639-7424","authenticated-orcid":false,"given":"Paula Lana","family":"de Miranda Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8576-6096","authenticated-orcid":false,"given":"L\u00edvia Pena","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4610-393X","authenticated-orcid":false,"given":"J\u00e9ssica Soares","family":"Malta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-6628","authenticated-orcid":false,"given":"Roberta M\u00e1rcia Marques","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0017-7338","authenticated-orcid":false,"given":"Adriano Max Moreira","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"issue":"S12","key":"7835_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ijc.22718","volume":"120","author":"DD Alexander","year":"2007","unstructured":"Alexander DD, Mink PJ, Adami HO, Cole P, Mandel JS, Oken MM, Trichopoulos D (2007) Multiple myeloma: a review of the epidemiologic literature. Int J Cancer 120(S12):40\u201361","journal-title":"Int J Cancer"},{"key":"7835_CR2","unstructured":"BRASIL. Minist\u00e9rio da Sa\u00fade. Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade. Portaria n\u00b0 708, de 06 de agosto de 2015. Aprova as diretrizes diagn\u00f3sticas e terap\u00eauticas do mieloma m\u00faltiplo. DOU de 07\/08\/2015. Available from: https:\/\/bvsms.saude.gov.br\/bvs\/saudelegis\/sas\/2015\/prt0708_06_08_2015.html"},{"issue":"5","key":"7835_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/ajh.25791","volume":"95","author":"SV Rajkumar","year":"2020","unstructured":"Rajkumar SV (2020) Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol 95(5):548\u2013567","journal-title":"Am J Hematol"},{"issue":"1","key":"7835_CR4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s12885-016-2410-2","volume":"16","author":"C Ramsenthaler","year":"2016","unstructured":"Ramsenthaler C, Osborne TR, Gao W, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ (2016) The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study. BMC Cancer 16(1):427. https:\/\/doi.org\/10.1186\/s12885-016-2410-2","journal-title":"BMC Cancer"},{"key":"7835_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11899-019-00500-4","volume":"14","author":"S Zanwar","year":"2019","unstructured":"Zanwar S, Abeykoon JP, Kapoor P (2019) Challenges and strategies in the management of multiple myeloma in the elderly population. Curr Hematol Malig Rep 14:70\u201382","journal-title":"Curr Hematol Malig Rep"},{"issue":"11","key":"7835_CR6","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.mayocp.2019.04.005","volume":"94","author":"R Warsame","year":"2019","unstructured":"Warsame R, D\u2019Souza A (2019) Patient reported outcomes have arrived: a practical overview for clinicians in using patient reported outcomes in oncology. Mayo. Clinic Proceedings 94(11):2291\u20132301","journal-title":"Clinic Proceedings"},{"issue":"5","key":"7835_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365\u2013376","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"7835_CR8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1080\/03007995.2021.1929136","volume":"37","author":"JS Malta","year":"2021","unstructured":"Malta JS, Silveira LP, Drummond PLDM, Costa NL, Dos Santo RM, Reis AMM, de P\u00e1dua CAM (2021) Validity and reliability of the QLQ-MY20 module for assessing the health-related quality of life in Brazilians with multiple myeloma. Curr Med Res Opin 37(7):1163\u20131169","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"7835_CR9","first-page":"2151","volume":"22","author":"CE Paiva","year":"2014","unstructured":"Paiva CE, Carneseca EC, Barroso EM, de Camargos MG, Alfano ACC, Rugno FC, Paiva BSR (2014) Further evaluation of the EORTC QLQ-C30 psychometric properties in a large Brazilian cancer patient cohort as a function of their educational status. Suppor Care in Cancer 22(8):2151\u20132160","journal-title":"Suppor Care in Cancer"},{"key":"7835_CR10","doi-asserted-by":"publisher","first-page":"104423","DOI":"10.1016\/j.archger.2021.104423","volume":"95","author":"HW Li","year":"2021","unstructured":"Li HW, Lee WJ, Lin MH, Peng LN, Loh CH, Chen LK, Lu CC (2021) Quality of life among community-dwelling middle-aged and older adults: function matters more than multimorbidity. Arch Gerontol Geriatr 95:104423","journal-title":"Arch Gerontol Geriatr"},{"issue":"5","key":"7835_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/jgs.15715","volume":"67","author":"TM Wildes","year":"2019","unstructured":"Wildes TM, Tuchman SA, Klepin HD, Mikhael J, Trinkaus K, Stockerl-Goldstein K, Colditz G (2019) Geriatric assessment in older adults with multiple myeloma. J Am Geriatr Soc 67(5):987\u2013991","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"7835_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/1078155219835303","volume":"26","author":"EG Um\u0131t","year":"2020","unstructured":"Um\u0131t EG, Baysal M, Bas V, Asker I, K\u0131rk\u0131zlar O, Dem\u0131r AM (2020) Polypharmacy and potentially inappropriate medication use in older patients with multiple myeloma, related to fall risk and autonomous neuropathy. J Oncol Pharm Pract 26(1):43\u201350","journal-title":"J Oncol Pharm Pract"},{"issue":"4","key":"7835_CR13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"DM Fick","year":"2019","unstructured":"American Geriatrics Society Beers Criteria\u00ae Update Expert Panel, Fick DM, Semla TP, Steinman M, Beizer J, Brandt N, Sandhu S (2019) American Geriatrics Society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc 67(4):674\u2013694","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"7835_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O'Mahony","year":"2015","unstructured":"O'Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P (2015) STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44(2):213\u2013218. https:\/\/doi.org\/10.1093\/ageing\/afu145","journal-title":"Age Ageing"},{"issue":"1","key":"7835_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/pharmaceutics15010230","volume":"15","author":"M Lavrador","year":"2023","unstructured":"Lavrador M, Cabral AC, Ver\u00edssimo MT, Fernandez-Llimos F, Figueiredo IV, Castel-Branco MM (2023) A universal pharmacological-based list of drugs with ACh activity. Pharmaceutics 15(1):230. https:\/\/doi.org\/10.3390\/pharmaceutics15010230","journal-title":"Pharmaceutics"},{"issue":"2","key":"7835_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/jpm12020207","volume":"12","author":"H Ramos","year":"2022","unstructured":"Ramos H, Moreno L, P\u00e9rez-Tur J, Ch\u00e1fer-Peric\u00e1s C, Garc\u00eda-Lluch G, Pardo J (2022) CRIDECO ACh load scale: an updated ACh burden scale. Comparison with the ACB scale in Spanish individuals with subjective memory complaints. J Pers Med 12(2):207. https:\/\/doi.org\/10.3390\/jpm12020207","journal-title":"J Pers Med"},{"issue":"8","key":"7835_CR17","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1007\/s00520-021-06008-z","volume":"29","author":"JH Lee","year":"2021","unstructured":"Lee JH, Lim J, Han SJ, do Moon S, Moon H, Lee SY, Kim H, Jung HW. (2021) Clinical outcomes associated with ACh burden in older hospitalized patients with advanced cancer: a single-center database study. Support Care Cancer 29(8):4607\u20134614. https:\/\/doi.org\/10.1007\/s00520-021-06008-z","journal-title":"Support Care Cancer"},{"issue":"5","key":"7835_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jpainsymman.2016.03.020","volume":"52","author":"MJ Hochman","year":"2016","unstructured":"Hochman MJ, Kamal AH, Wolf SP, Samsa GP, Currow DC, Abernethy AP, LeBlanc TW (2016) Anticholinergic drug burden in noncancer versus cancer patients near the end of life. J Pain Symptom Manage 52(5):737\u2013743 e3","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"7835_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/0269216309102528","volume":"23","author":"M Agar","year":"2009","unstructured":"Agar M, Currow D, Plummer J, Seidel R, Carnahan R, Abernethy AP (2009) Changes in anticholinergic load from regular prescribed medications in palliative care as death approaches. Palliat Med 23(3):257\u2013265","journal-title":"Palliat Med"},{"issue":"8","key":"7835_CR20","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/jnci\/djab007","volume":"113","author":"NR Fillmore","year":"2021","unstructured":"Fillmore NR, DuMontier C, Yildirim C, La J, Epstein MM, Cheng D, Cirstea D, Yellapragada S, Abel GA, Gaziano JM, Do N, Brophy M, Kim DH, Munshi NC, Driver JA (2021) Defining multimorbidity and its impact in older United States veterans newly treated for multiple myeloma. J Natl Cancer Inst 113(8):1084\u20131093. https:\/\/doi.org\/10.1093\/jnci\/djab007","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"7835_CR21","doi-asserted-by":"publisher","first-page":"e0253336","DOI":"10.1371\/journal.pone.0253336","volume":"16","author":"J Reinold","year":"2021","unstructured":"Reinold J, Braitmaier M, RiedelO HU (2021) Anticholinergic burden: first comprehensive analysis using claims data shows large variation by age and sex. PloS One. 16(6):e0253336","journal-title":"PloS One."},{"key":"7835_CR22","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1590\/1413-81232022276.12452021","volume":"27","author":"ECP Pinto","year":"2022","unstructured":"Pinto ECP, Silva AMR, Cabrera MAS, Baldoni ADO, Alfieri DF, Andrade GFD, Girotto E (2022) O uso de f\u00e1rmacos anticolin\u00e9rgicos e fatores associados em adultos de meia-idade e idosos. Cien Saude Colet 27:2279\u20132290","journal-title":"Cien Saude Colet"},{"key":"7835_CR23","volume-title":"EORTC Quality of life","author":"EORTC","year":"2019","unstructured":"EORTC (2019) EORTC Quality of life. https:\/\/qol.eortc.org\/modules\/. Accessed: 02\/2019."},{"issue":"11","key":"7835_CR24","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.ejca.2007.04.022","volume":"43","author":"K Cocks","year":"2007","unstructured":"Cocks K, Cohen D, Wisl\u00f8ff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A, Graham L, Phillips A, Stead M, Velikova G, Brown J (2007) An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer 43(11):1670\u20131678. https:\/\/doi.org\/10.1016\/j.ejca.2007.04.022","journal-title":"Eur J Cancer"},{"key":"7835_CR25","first-page":"1855","volume":"66","author":"LY Etto","year":"2011","unstructured":"Etto LY, Morel VM, Silva VC, Hungria V, Ciconelli RM, Almeida MS, Colleoni GW (2011) Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patients. Clinics 66:1855\u20131859","journal-title":"Clinics"},{"issue":"2","key":"7835_CR26","doi-asserted-by":"publisher","first-page":"eAO4435","DOI":"10.31744\/einstein_journal\/2019AO4435","volume":"17","author":"RT Nery","year":"2019","unstructured":"Nery RT, Reis AMM (2019) Development of a Brazilian anticholinergic activity drug scale. Einstein (S\u00e3o Paulo) 17(2):eAO4435. https:\/\/doi.org\/10.31744\/einstein_journal\/2019AO4435","journal-title":"Einstein (S\u00e3o Paulo)"},{"key":"7835_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.maturitas.2020.07.006","volume":"142","author":"KR Yrjana","year":"2020","unstructured":"Yrjana KR, Keevil VL, Soiza RL, Luben RN, Wareham NJ, Khaw KT, Myint PK (2020) Anticholinergic medication exposure predicts poor physical capability: findings from a large prospective cohort study in England. Maturitas 142:55\u201363","journal-title":"Maturitas"},{"issue":"2","key":"7835_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/pds.5085","volume":"30","author":"KR Yrjana","year":"2021","unstructured":"Yrjana KR, Neal SR, Soiza RL, Keevil V, Luben RN, Wareham NJ, Myint PK (2021) Baseline anticholinergic burden from medications predicts poorer baseline and long-term health-related quality of life in 16 675 men and women of EPIC-Norfolk prospective population-based cohort study. Pharmacoepidemiol Drug Saf 30(2):135\u2013143","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"7835_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jamda.2020.05.065","volume":"22","author":"C Stewart","year":"2021","unstructured":"Stewart C, Yrjana K, Kishor M, Soiza RL, Taylor-Rowan M, Quinn TJ, Myint PK (2021) Anticholinergic burden measures predict older people\u2019s physical function and quality of life: a systematic review. J Am Med Dir Assoc 22(1):56\u201364","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"7835_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s40264-021-01043-5","volume":"44","author":"A Ziad","year":"2021","unstructured":"Ziad A, Berr C, Ruiz F, B\u00e9gaud B, Lemogne C, Goldberg M, Mura T (2021) ACh activity of psychotropic drugs and cognitive impairment among participants aged 45 and over: The CONSTANCES Study. Drug Saf 44(5):565\u2013579","journal-title":"Drug Saf"},{"issue":"8","key":"7835_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.annepidem.2018.05.011","volume":"28","author":"AD Ablett","year":"2018","unstructured":"Ablett AD, Wood AD, BarrR GJ, Black AJ, Macdonald HM, Myint PK (2018) A high anticholinergic burden is associated with a history of falls in the previous year in middle-aged women: findings from the Aberdeen Prospective Osteoporosis Screening Study. Ann Epidemiol 28(8):557\u2013562","journal-title":"Ann Epidemiol"},{"issue":"10","key":"7835_CR32","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1136\/jnnp-2018-318190","volume":"89","author":"A Ziad","year":"2018","unstructured":"Ziad A, Olekhnovitch R, Ruiz F, Berr C, B\u00e9gaud B, Goldberg M, Mura T (2018) Anticholinergic drug use and cognitive performances in middle age: findings from the CONSTANCES cohort. J Neurol Neurosurg Psychiatry 89(10):1107\u20131115","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"7835_CR33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s40266-017-0486-2","volume":"34","author":"B Cossette","year":"2017","unstructured":"Cossette B, Bagna M, Sene M, Sirois C, Lefebvre GP, Germain O, Payette H (2017) Association between anticholinergic drug use and health-related quality of life in community-dwelling older adults. Drugs Aging 34(10):785\u2013792","journal-title":"Drugs Aging"},{"issue":"9","key":"7835_CR34","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00228-022-03361-8","volume":"78","author":"ANM Dos Santos","year":"2022","unstructured":"Dos Santos ANM, Junior GAAG, Bense\u00f1or IM, Goulart AC, Brunoni AR, Viana MC, Suemoto CK (2022) Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study. Eur J Clin Pharmacol 78(9):1527\u20131534","journal-title":"Eur J Clin Pharmacol"},{"key":"7835_CR35","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"10272","author":"NW van de Donk","year":"2021","unstructured":"van de Donk NW, Pawlyn C, Yong KL (2021) Multiple myeloma. Lancet 10272:410\u2013427","journal-title":"Lancet"},{"issue":"1","key":"7835_CR36","first-page":"62","volume":"5","author":"A Tiisanoja","year":"2020","unstructured":"Tiisanoja A, Syrj\u00e4l\u00e4 AM, Kullaa A, Yl\u00f6stalo P (2020) Anticholinergic burden and dry mouth in middle-aged people. JDR Clin Trans Res 5(1):62\u201370","journal-title":"JDR Clin Trans Res"},{"key":"7835_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.10.003","volume":"118","author":"JM Giesinger","year":"2020","unstructured":"Giesinger JM, FLC L, Aaronson NK, Arraras JI, Caocci G, Efficace F, Groenvold M, van Leeuwen M, Petersen MA, Ramage J, Tomaszewski KA, Young T, Holzner B, EORTC Quality of Life Group (2020) Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research. J Clin Epidemiol 118:1\u20138. https:\/\/doi.org\/10.1016\/j.jclinepi.2019.10.003","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"7835_CR38","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s00520-015-2644-6","volume":"23","author":"R Baz","year":"2015","unstructured":"Baz R, Lin HM, Hui AM, Harvey RD, Colson K, Gallop K, Richardson P (2015) Development of a conceptual model to illustrate the impact of multiple myeloma and its treatment on health-related quality of life. Support Care Cancer 23(9):2789\u20132797","journal-title":"Support Care Cancer"},{"issue":"1","key":"7835_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11764-019-00837-y","volume":"14","author":"ZR Babcock","year":"2020","unstructured":"Babcock ZR, Kogut SJ, Vyas A (2020) Association between polypharmacy and health-related quality of life among cancer survivors in the United States. J Cancer Surviv 14(1):89\u201399","journal-title":"J Cancer Surviv"},{"issue":"5","key":"7835_CR40","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jgo.2021.12.010","volume":"13","author":"D Outlaw","year":"2022","unstructured":"Outlaw D, Dai C, Al-Obaidi M, Harmon C, Giri S, Bhatia S, Williams GR (2022) The association of polypharmacy with functional status impairments, frailty, and health-related quality of life in older adults with gastrointestinal malignancy-results from the Cancer and Aging Resilience Evaluation (CARE) registry. J Geriatr Oncol 13(5):624\u2013628","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"7835_CR41","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/1078155219851550","volume":"26","author":"K Sweiss","year":"2020","unstructured":"Sweiss K, Calip GS, Wirth S, Rondelli D, Patel P (2020) Polypharmacy and potentially inappropriate medication use is highly prevalent in multiple myeloma patients and is improved by a collaborative physician\u2013pharmacist clinic. J Oncol Pharm Pract 26(3):536\u2013542","journal-title":"J Oncol Pharm Pract"},{"issue":"5","key":"7835_CR42","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/jgs.15715","volume":"67","author":"TM Wildes","year":"2019","unstructured":"Wildes TM, Tuchman SA, Klepin HD, Mikhael J, Trinkaus K, Stockerl-Goldstein K, Colditz G (2019) Geriatric assessment in older adults with multiple myeloma. J Am Geriatr Soc 67(5):987\u2013991","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"7835_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1001\/jamainternmed.2019.5096","volume":"180","author":"R Romskaug","year":"2020","unstructured":"Romskaug R, Skovlund E, Straand J, Molden E, Kersten H, Pitkala KH, WyllerTB (2020) Effect of clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician for improving health-related quality of life in home-dwelling older patients receiving polypharmacy: a cluster randomized clinical trial. JAMA Intern Med 180(2):181\u2013189","journal-title":"JAMA Intern Med"},{"key":"7835_CR44","doi-asserted-by":"publisher","first-page":"612696","DOI":"10.3389\/fmed.2021.612696","volume":"8","author":"NM Kaweme","year":"2021","unstructured":"Kaweme NM, Changwe GJ, Zhou F (2021) Approaches and challenges in the management of multiple myeloma in the very old: future treatment prospects. Front Med 8:612696","journal-title":"Front Med"},{"key":"7835_CR45","first-page":"e266","volume":"41","author":"TM Wildes","year":"2021","unstructured":"Wildes TM, Artz AS (2021) Characterize, optimize, and harmonize: caring for older adults with hematologic malignancies. Am J Clin Oncol 41:e266\u2013e274","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"7835_CR46","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/17474086.2019.1613886","volume":"12","author":"S Seitzler","year":"2019","unstructured":"Seitzler S, Finley-Oliver E, Simonelli C, Baz R (2019) Quality of life in multiple myeloma: considerations and recommendations. Expert Rev Hematol 12(6):419\u2013424","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"7835_CR47","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/bjh.14058","volume":"174","author":"D Robinson Jr","year":"2016","unstructured":"Robinson D Jr, Esseltine DL, Regnault A, Meunier J, Liu K, van de Velde H (2016) The influence of baseline characteristics and disease stage on health-related quality of life in multiple myeloma: findings from six randomized controlled trials. Br J Haematol 174(3):368\u2013381","journal-title":"Br J Haematol"},{"issue":"5","key":"7835_CR48","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1182\/blood-2017-09-746420","volume":"131","author":"GA Abel","year":"2018","unstructured":"Abel GA, Klepin HD (2018) Frailty and the management of hematologic malignancies. Blood 131(5):515\u2013524","journal-title":"Blood"},{"issue":"1","key":"7835_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-020-07178-5","volume":"20","author":"L Xu","year":"2020","unstructured":"Xu L, Wang X, Pan X, Wang X, Wang Q, Wu B, Li J (2020) Education level as a predictor of survival in patients with multiple myeloma. BMC Cancer 20(1):1\u201310","journal-title":"BMC Cancer"},{"issue":"20","key":"7835_CR50","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1002\/cncr.32357","volume":"125","author":"RW Hsieh","year":"2019","unstructured":"Hsieh RW, GoRS AJP, Kapoor P, KumarSK GMA, Paludo J (2019) Characteristics of long-term survivors with multiple myeloma: a National Cancer Data Base analysis. Cancer 125(20):3574\u20133581","journal-title":"Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07835-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07835-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07835-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T10:04:38Z","timestamp":1689329078000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07835-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["7835"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07835-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"16 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The Research Ethics Committee of the Federal University of Minas Gerais approved the research (CAAE 07491119.8.0000.5149).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"379"}}